Protein-protein Interactions in Bacteria: a Promising and Challenging Avenue Towards the Discovery of New Antibiotics

Overview

Journal Beilstein J Org Chem

Specialty Chemistry

Date 2018 Dec 15

PMID 30546472

Citations 14

Authors

Laura Carro

Affiliations

Soon will be listed here.

Abstract

Antibiotics are potent pharmacological weapons against bacterial infections; however, the growing antibiotic resistance of microorganisms is compromising the efficacy of the currently available pharmacotherapies. Even though antimicrobial resistance is not a new problem, antibiotic development has failed to match the growth of resistant pathogens and hence, it is highly critical to discover new anti-infective drugs with novel mechanisms of action which will help reducing the burden of multidrug-resistant microorganisms. Protein-protein interactions (PPIs) are involved in a myriad of vital cellular processes and have become an attractive target to treat diseases. Therefore, targeting PPI networks in bacteria may offer a new and unconventional point of intervention to develop novel anti-infective drugs which can combat the ever-increasing rate of multidrug-resistant bacteria. This review describes the progress achieved towards the discovery of molecules that disrupt PPI systems in bacteria for which inhibitors have been identified and whose targets could represent an alternative lead discovery strategy to obtain new anti-infective molecules.

Citing Articles

A cell-free strategy for host-specific profiling of intracellular antibiotic sensitivity and resistance.

Chengan K, Hind C, Stanley M, Wand M, Nagappa L, Howland K NPJ Antimicrob Resist. 2025; 1(1):16.

PMID: 39843793 PMC: 11721408. DOI: 10.1038/s44259-023-00018-z.

Peptide design to control protein-protein interactions.

van Wier S, Beekman A Chem Soc Rev. 2025; 54(4):1684-1698.

PMID: 39817557 PMC: 11736853. DOI: 10.1039/d4cs00243a.

Impairing protein-protein interactions in an essential tRNA modification complex: An innovative antimicrobial strategy against Pseudomonas aeruginosa.

Bollati M, Fasola E, Pieraccini S, Freddi F, Cocomazzi P, Oliva F J Pept Sci. 2024; 31(2):e3658.

PMID: 39434676 PMC: 11669939. DOI: 10.1002/psc.3658.

An overview of the two-component system GarR/GarS role on antibiotic production in Streptomyces coelicolor.

Cruz-Bautista R, Zelarayan-Aguero A, Ruiz-Villafan B, Escalante-Lozada A, Rodriguez-Sanoja R, Sanchez S Appl Microbiol Biotechnol. 2024; 108(1):306.

PMID: 38656376 PMC: 11043171. DOI: 10.1007/s00253-024-13136-z.

Structural assembly of the bacterial essential interactome.

Gomez Borrego J, Torrent Burgas M Elife. 2024; 13.

PMID: 38226900 PMC: 10863985. DOI: 10.7554/eLife.94919.

References

Dong M, Pfeiffer B, Altmann K . Recent developments in natural product-based drug discovery for tuberculosis. Drug Discov Today. 2016; 22(3):585-591. DOI: 10.1016/j.drudis.2016.11.015. View

Cossar P, Abdel-Hamid M, Ma C, Sakoff J, Trinh T, Gordon C . Small-Molecule Inhibitors of the NusB-NusE Protein-Protein Interaction with Antibiotic Activity. ACS Omega. 2018; 2(7):3839-3857. PMC: 6044933. DOI: 10.1021/acsomega.7b00273. View

Wells J, McClendon C . Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature. 2007; 450(7172):1001-9. DOI: 10.1038/nature06526. View

Bi E, Lutkenhaus J . FtsZ ring structure associated with division in Escherichia coli. Nature. 1991; 354(6349):161-4. DOI: 10.1038/354161a0. View

Wuchty S, Rajagopala S, Blazie S, Parrish J, Khuri S, Finley Jr R . The Protein Interactome of and Bacterial Meta-interactomes Improve Function Predictions. mSystems. 2017; 2(3). PMC: 5513735. DOI: 10.1128/mSystems.00019-17. View

Indiani C, ODonnell M . The replication clamp-loading machine at work in the three domains of life. Nat Rev Mol Cell Biol. 2006; 7(10):751-61. DOI: 10.1038/nrm2022. View

Brown E, Wright G . Antibacterial drug discovery in the resistance era. Nature. 2016; 529(7586):336-43. DOI: 10.1038/nature17042. View

Hu P, Janga S, Babu M, Diaz-Mejia J, Butland G, Yang W . Global functional atlas of Escherichia coli encompassing previously uncharacterized proteins. PLoS Biol. 2009; 7(4):e96. PMC: 2672614. DOI: 10.1371/journal.pbio.1000096. View

Kling A, Lukat P, Almeida D, Bauer A, Fontaine E, Sordello S . Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins. Science. 2015; 348(6239):1106-12. DOI: 10.1126/science.aaa4690. View

10.

Waga S, Stillman B . The DNA replication fork in eukaryotic cells. Annu Rev Biochem. 1998; 67:721-51. DOI: 10.1146/annurev.biochem.67.1.721. View

11.

Voter A, Killoran M, Ananiev G, Wildman S, Hoffmann F, Keck J . A High-Throughput Screening Strategy to Identify Inhibitors of SSB Protein-Protein Interactions in an Academic Screening Facility. SLAS Discov. 2017; 23(1):94-101. PMC: 5667550. DOI: 10.1177/2472555217712001. View

12.

Makley L, Gestwicki J . Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions. Chem Biol Drug Des. 2012; 81(1):22-32. PMC: 3531880. DOI: 10.1111/cbdd.12066. View

13.

Arkin M, Wells J . Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov. 2004; 3(4):301-17. DOI: 10.1038/nrd1343. View

14.

Robinson A, Causer R, Dixon N . Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target. Curr Drug Targets. 2011; 13(3):352-72. PMC: 3290774. DOI: 10.2174/138945012799424598. View

15.

Kuhner S, van Noort V, Betts M, Leo-Macias A, Batisse C, Rode M . Proteome organization in a genome-reduced bacterium. Science. 2009; 326(5957):1235-40. DOI: 10.1126/science.1176343. View

16.

Zhong M, Gadek T, Bui M, Shen W, Burnier J, Barr K . Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye. ACS Med Chem Lett. 2014; 3(3):203-6. PMC: 4025648. DOI: 10.1021/ml2002482. View

17.

Mosyak L, Zhang Y, Glasfeld E, Haney S, Stahl M, Seehra J . The bacterial cell-division protein ZipA and its interaction with an FtsZ fragment revealed by X-ray crystallography. EMBO J. 2000; 19(13):3179-91. PMC: 313961. DOI: 10.1093/emboj/19.13.3179. View

18.

Shimoda Y, Shinpo S, Kohara M, Nakamura Y, Tabata S, Sato S . A large scale analysis of protein-protein interactions in the nitrogen-fixing bacterium Mesorhizobium loti. DNA Res. 2008; 15(1):13-23. PMC: 2650630. DOI: 10.1093/dnares/dsm028. View

19.

Parrish J, Yu J, Liu G, Hines J, Chan J, Mangiola B . A proteome-wide protein interaction map for Campylobacter jejuni. Genome Biol. 2007; 8(7):R130. PMC: 2323224. DOI: 10.1186/gb-2007-8-7-r130. View

20.

Sutherland A, Alvarez J, Ding W, Foreman K, Kenny C, Labthavikul P . Structure-based design of carboxybiphenylindole inhibitors of the ZipA-FtsZ interaction. Org Biomol Chem. 2003; 1(23):4138-40. DOI: 10.1039/b312016c. View